Abstract
The series of derivatives of 7-arylsulfonyl-3,5(2H)-dioxo-6,7-dihydroimidazo [2,1-c] [1,2,4]triazole was obtained as a result of condensation of 1-arylsulfonyl-2-hydrazinoimidazolidin-4- ones with 1,1-carbonyldiimidazole. Based on the structure of imidazotriazole derivatives it is likely to happen that these compounds should reveal antifungal activity.
References
1. Rządkowska M., Sztanke K.: Synthesis of new derivatives of 7-arylsulfony-3 (2H)-oxo, thioxo, imino-5-oxo-6,7-dihydroimidazo [2,1-c][1,2,4] triazole. Annales UMCS, Sect. DDD, 15, 21, 2002.
2. Schiro k H., Mittendor f J. et al.: Preparation of imidazo [2,1-c][1,2,4] triazoles as guanylate cyclase activators for treatment of cardiovascular diseases.: WO, 2008, 061657.
3. Singh H., Shukla K. N. et al: Synthesis of some new heterocyclic compounds containing bridgehead nitrogen atom as antifungal drugs. Indian J. Pharm. Sci., 52, 9, 1990.
4. Sztanke K., Pasternak K. et al.: Synthesis of imidazoline and imidazo[2,1-c][1,2,4] triazole aryl derivatives containing the methy i thio group as possible antibacterial agents. Bioorganic & Medicinal Chemistry, 14, 11, 2006.
5. Sztank e K., Rządkowska M.: Synthesis of new 3-unsubstituted and 3-substituted derivatives of 7-aryl-5H-6,7-dihydroimidazo [2,1-c][1,2,4] triazole.: Annales UMCS, Sect. DDD, 2003, 16, 21.
6. Wannamaker M., Salitur o F. et al.: Compounds useful as inhibitors of janus kinases. WO, 2008, 116139.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
Copyright (c) 2009 Authors